Royal Bank of Canada’s NRX Pharmaceuticals NRXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,013
| Closed | -$10K | – | 6721 |
|
|
2024
Q2 | $10K | Buy |
4,013
+4,000
| +30,769% | +$9.97K | ﹤0.01% | 5951 |
|
|
2024
Q1 | $0 | Sell |
13
-15,008
| -100% | – | ﹤0.01% | 6824 |
|
|
2023
Q4 | $69K | Sell |
15,021
-2,021
| -12% | -$9.28K | ﹤0.01% | 5301 |
|
|
2023
Q3 | $44K | Sell |
17,042
-81
| -0.5% | -$209 | ﹤0.01% | 5362 |
|
|
2023
Q2 | $83K | Buy |
17,123
+17,110
| +131,615% | +$82.9K | ﹤0.01% | 5028 |
|
|
2023
Q1 | $0 | Hold |
13
| – | – | ﹤0.01% | 6839 |
|
|
2022
Q4 | $0 | Sell |
13
-19
| -59% | – | ﹤0.01% | 7010 |
|
|
2022
Q3 | $0 | Sell |
32
-20
| -38% | – | ﹤0.01% | 7159 |
|
|
2022
Q2 | $0 | Buy |
+52
| New | – | ﹤0.01% | 7046 |
|
|
2021
Q3 | – | Sell |
-800
| Closed | -$93K | – | 7197 |
|
|
2021
Q2 | $93K | Buy |
+800
| New | +$93K | ﹤0.01% | 5170 |
|